March 13, 2025
Enroll in the Model Master Files Course
FREE
Enroll in the Model Master Files course to access all lessons and resources.
Create a free FDA Learning Cache account or sign in with your existing account to get started.
Supporting Resources – Access with FREE Enrollment (above)
Download Presentation Slides & Transcript (Model Master Files: Advancing Modeling and Simulation)
Presentations
About This Course
This event provides an update on FDA’s efforts related to model master files (MMFs). The agenda includes presentations by FDA staff that will focus on an introduction and overview of MMFs, considerations for developing and submitting MMFs to support ANDAs using a Type V DMF, and a cross-comparison to other types of DMFs, including lessons learned.
Intended Audience
This webinar is designed for members of the generic drug industry, including:
- Current and potential holders and applicants of abbreviated new drug applications (ANDAs) who are interested in using modeling and simulation to support their applications
- Prospective drug master file (DMF) holders
- Regulatory reviewers for generic drug development and assessments
- Industry consultants focused on bioequivalence approaches
- Clinical research coordinators and foreign regulators
Topics Covered
- Describe the purpose, benefits, and challenges of MMFs
- Understand how to navigate the process for using the Type V DMF for MMF submissions to support ANDAs
- Recognize the value MMFs provide to the development, assessment, and approval of high-quality generic drugs
- Implement best practices for MMF submissions in your work
Resources
- Federal Register Notice: Establishment of a Public Docket: Use of a Type V Drug Master File for Model Master File Submissions to Support Abbreviated New Drug Applications
- Model-Integrated Evidence (MIE) Industry Meeting Pilot Between FDA and Generic Drug Applicants